{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T00:51:20Z","timestamp":1794012680962,"version":"4.8.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,8,22]],"date-time":"2019-08-22T00:00:00Z","timestamp":1566432000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,8,22]],"date-time":"2019-08-22T00:00:00Z","timestamp":1566432000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007458","name":"Qatar Foundation","doi-asserted-by":"publisher","award":["NPRP 4-248-3-076"],"award-info":[{"award-number":["NPRP 4-248-3-076"]}],"id":[{"id":"10.13039\/100007458","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Endocr Disord"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12902-019-0412-1","type":"journal-article","created":{"date-parts":[[2019,8,22]],"date-time":"2019-08-22T11:03:51Z","timestamp":1566471831000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Glycated hemoglobin versus oral glucose tolerance test in the identification of subjects with prediabetes in Qatari population"],"prefix":"10.1186","volume":"19","author":[{"given":"Saadallah","family":"Iskandar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayman","family":"Migahid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dalia","family":"Kamal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osama","family":"Megahed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralph A.","family":"DeFronzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmoud","family":"Zirie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amin","family":"Jayyousi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmood","family":"Al Jaidah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4556-1787","authenticated-orcid":false,"given":"Muhammad","family":"Abdul-Ghani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,8,22]]},"reference":[{"key":"412_CR1","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.diabres.2009.10.007","volume":"87","author":"JE Shaw","year":"2010","unstructured":"Shaw JE, Sicree RA, Zimmet PZ. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract. 2010;87:4\u201314.","journal-title":"Diabetes Res Clin Pract"},{"key":"412_CR2","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1001\/jama.2015.10029","volume":"314","author":"A Menke","year":"2015","unstructured":"Menke A, Casagrande S, Geiss L, Cowie C. Prevalence of and trends in diabetes among adults in the United States, 1988-2012. JAMA. 2015;314:1021\u20139.","journal-title":"JAMA"},{"key":"412_CR3","doi-asserted-by":"publisher","first-page":"308","DOI":"10.2337\/diacare.26.2.308","volume":"26","author":"LA Jaber","year":"2003","unstructured":"Jaber LA, Brown MB, Hammad A, Nowak SN, Zhu Q, Ghafoor A, Herman WH. Epidemiology of diabetes among Arab Americans. Diabetes Care. 2003;26:308\u201313.","journal-title":"Diabetes Care"},{"key":"412_CR4","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.diabres.2009.02.003","volume":"84","author":"A Bener","year":"2009","unstructured":"Bener A, Zirie M, Janahi IM, Al-Hamaq AO, Musallam M, Wareham NJ. Prevalence of diagnosed and undiagnosed diabetes mellitus and its risk factors in a population-based study of Qatar. Diabetes Res Clin Pract. 2009;84:99\u2013106.","journal-title":"Diabetes Res Clin Pract"},{"key":"412_CR5","doi-asserted-by":"publisher","first-page":"936","DOI":"10.2337\/diacare.21.6.936","volume":"21","author":"F al-Mahroos","year":"1998","unstructured":"al-Mahroos F, McKeigue PM. High prevalence of diabetes in Bahrainis. Associations with ethnicity and raised plasma cholesterol. Diabetes Care. 1998;21:936\u201342.","journal-title":"Diabetes Care"},{"key":"412_CR6","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1056\/NEJMoa1010949","volume":"364","author":"RA DeFronzo","year":"2011","unstructured":"DeFronzo RA, Tripathy D, Schwenke DC, Banerji M, Bray GA, Buchanan TA, Clement SC, Henry RR, Hodis HN, Kitabchi AE, Mack WJ, Mudaliar S, Ratner RE, Williams K, Stentz FB, Musi N, Reaven PD, ACT NOW Study. Pioglitazone for diabetes prevention in impaired glucose tolerance. N Engl J Med. 2011;364:1104\u201315.","journal-title":"N Engl J Med"},{"key":"412_CR7","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1016\/S0140-6736(06)69420-8","volume":"368","author":"HC Gerstein","year":"2006","unstructured":"DREAM (Diabetes REduction Assessment with ramipril and rosiglitazone Medication) Trial Investigators, Gerstein HC, Yusuf S, Bosch J, Pogue J, Sheridan P, Dinccag N, Hanefeld M, Hoogwerf B, Laakso M, Mohan V, Shaw J, Zinman B, Holman RR. Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial. Lancet. 2006;368:1096\u2013105.","journal-title":"Lancet."},{"key":"412_CR8","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1056\/NEJMoa012512","volume":"346","author":"WC Knowler","year":"2002","unstructured":"Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, Nathan DM, Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346:393\u2013403.","journal-title":"N Engl J Med"},{"issue":"Suppl 2","key":"412_CR9","doi-asserted-by":"publisher","first-page":"S194","DOI":"10.2337\/dc09-S309","volume":"32","author":"MA Abdul-Ghani","year":"2009","unstructured":"Abdul-Ghani MA, DeFronzo RA. Plasma glucose concentration and prediction of future risk of type 2 diabetes. Diabetes Care. 2009;32(Suppl 2):S194\u20138.","journal-title":"Diabetes Care"},{"key":"412_CR10","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.2337\/dc05-2179","volume":"29","author":"MA Abdul-Ghani","year":"2006","unstructured":"Abdul-Ghani MA, Tripathy D, DeFronzo RA. Contributions of beta-cell dysfunction and insulin resistance to the pathogenesis of impaired glucose tolerance and impaired fasting glucose. Diabetes Care. 2006;29:1130\u20139.","journal-title":"Diabetes Care"},{"key":"412_CR11","doi-asserted-by":"publisher","first-page":"S44","DOI":"10.2337\/dci18-0007","volume":"41","author":"American Diabetes Association","year":"2018","unstructured":"American Diabetes Association. Prevention or delay of type 2 diabetes. Diabetes Care. 2018;41:S44\u201354.","journal-title":"Diabetes Care"},{"key":"412_CR12","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.2337\/dc09-9033","volume":"32","author":"International Expert Committee","year":"2009","unstructured":"International Expert Committee. International expert committee report on the role of the A1C assay in the diagnosis of diabetes. Diabetes Care. 2009;32:1327\u201334.","journal-title":"Diabetes Care"},{"issue":"8","key":"412_CR13","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1111\/pedi.12461","volume":"18","author":"S Ehehalt","year":"2017","unstructured":"Ehehalt S, Wiegand S, K\u00f6rner A, Schweizer R, Liesenk\u00f6tter KP, Partsch CJ, Blumenstock G, Spielau U, Denzer C, Ranke MB, Neu A, Binder G, Wabitsch M, Kiess W, Reinehr T. Low association between fasting and OGTT stimulated glucose levels with HbA1c in overweight children and adolescents. Pediatr Diabetes. 2017;18(8):734\u201341 [Epub ahead of print].","journal-title":"Pediatr Diabetes"},{"key":"412_CR14","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1111\/dme.13270","volume":"34","author":"SL Jackson","year":"2017","unstructured":"Jackson SL, Safo SE, Staimez LR, Olson DE, Narayan KMV, Long Q, Lipscomb J, Rhee MK, Wilson PWF, Tomolo AM, Phillips LS. Glucose challenge test screening for prediabetes and early diabetes. Diabet Med. 2017;34:716\u201324.","journal-title":"Diabet Med"},{"key":"412_CR15","doi-asserted-by":"publisher","first-page":"2325","DOI":"10.2337\/dc15-1078","volume":"38","author":"SV Eastwood","year":"2015","unstructured":"Eastwood SV, Tillin T, Sattar N, Forouhi NG, Hughes AD, Chaturvedi N. Associations between prediabetes, by three different diagnostic criteria, and incident CVD differ in south Asians and Europeans. Diabetes Care. 2015;38:2325\u20133.","journal-title":"Diabetes Care"},{"key":"412_CR16","doi-asserted-by":"publisher","first-page":"e0136734","DOI":"10.1371\/journal.pone.0136734","volume":"10","author":"IG van Valkengoed","year":"2015","unstructured":"van Valkengoed IG, Vlaar EM, Nierkens V, Middelkoop BJ, Stronks K. The uptake of screening for type 2 diabetes and prediabetes by means of glycated hemoglobin versus the Oral glucose tolerance test among 18 to 60-year-old people of south Asian origin: a comparative Study. PLoS One. 2015;10:e0136734.","journal-title":"PLoS One"},{"key":"412_CR17","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1111\/dme.12895","volume":"33","author":"SV Eastwood","year":"2016","unstructured":"Eastwood SV, Tillin T, Mayet J, Shibata DK, Wright A, Heasman J, Beauchamp N, Forouhi NG, Hughes AD, Chaturvedi N. Ethnic differences in cross-sectional associations between impaired glucose regulation, identified by oral glucose tolerance test or HbA1c values, and cardiovascular disease in a cohort of European and south Asian origin. Diabet Med. 2016;33:340\u20137.","journal-title":"Diabet Med"},{"key":"412_CR18","doi-asserted-by":"publisher","first-page":"1997","DOI":"10.1210\/jc.2014-4139","volume":"100","author":"J Li","year":"2015","unstructured":"Li J, Ma H, Na L, Jiang S, Lv L, Li G, Zhang W, Na G, Li Y, Sun C. Increased hemoglobin A1c threshold for prediabetes remarkably improving the agreement between A1c and oral glucose tolerance test criteria in obese population. J Clin Endocrinol Metab. 2015;100:1997\u20132005.","journal-title":"J Clin Endocrinol Metab"},{"key":"412_CR19","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1007\/BF00280883","volume":"28","author":"DR Matthews","year":"1985","unstructured":"Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412\u20139.","journal-title":"Diabetologia."},{"key":"412_CR20","doi-asserted-by":"publisher","first-page":"3143","DOI":"10.1161\/circ.106.25.3143","volume":"106","author":"National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III)","year":"2002","unstructured":"National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). Third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III) final report. Circulation. 2002;106:3143\u201321.","journal-title":"Circulation"},{"key":"412_CR21","doi-asserted-by":"publisher","first-page":"575","DOI":"10.7326\/0003-4819-136-8-200204160-00006","volume":"136","author":"MP Stern","year":"2002","unstructured":"Stern MP, Williams K, Haffner SM. Identification of persons at high risk for type 2 diabetes mellitus: do we need the oral glucose tolerance test? Ann Intern Med. 2002;136:575\u201381.","journal-title":"Ann Intern Med"},{"key":"412_CR22","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.2337\/diacare.20.7.1183","volume":"20","author":"The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus","year":"1997","unstructured":"The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care. 1997;20:1183\u201397.","journal-title":"Diabetes Care"},{"key":"412_CR23","doi-asserted-by":"publisher","first-page":"2354","DOI":"10.1210\/jc.2011-0246","volume":"96","author":"RA DeFronzo","year":"2011","unstructured":"DeFronzo RA, Abdul-Ghani MA. Preservation of beta-cell function: the key to diabetes prevention. J Clin Endocrinol Metab. 2011;96:2354\u201366.","journal-title":"J Clin Endocrinol Metab"},{"key":"412_CR24","doi-asserted-by":"publisher","first-page":"E1680","DOI":"10.1210\/jc.2011-1148","volume":"96","author":"NR Pinelli","year":"2011","unstructured":"Pinelli NR, Jantz AS, Martin ET, Jaber LA. Sensitivity and specificity of glycated hemoglobin as a diagnostic test for diabetes and prediabetes in Arabs. J Clin Endocrinol Metab. 2011;96:E1680\u20133.","journal-title":"J Clin Endocrinol Metab"},{"key":"412_CR25","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.2337\/dc10-1352","volume":"34","author":"M Kanat","year":"2011","unstructured":"Kanat M, Winnier D, Norton L, Arar N, Jenkinson C, DeFronzo RA, Abdul-Ghani MA. The relationship between beta cell function and glycated hemoglobin. Diabetes Care. 2011;34:1006\u201310.","journal-title":"Diabetes Care"},{"key":"412_CR26","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/j.jacc.2011.08.080","volume":"59","author":"SM Grundy","year":"2012","unstructured":"Grundy SM. Pre-diabetes, metabolic syndrome, and cardiovascular risk. J Am Coll Cardiol. 2012;59:635\u201343.","journal-title":"J Am Coll Cardiol"},{"key":"412_CR27","doi-asserted-by":"publisher","first-page":"281","DOI":"10.2337\/dc08-1264","volume":"32","author":"MA Abdul-Ghani","year":"2009","unstructured":"Abdul-Ghani MA, Lyssenko V, Tuomi T, DeFronzo RA, Groop L. Fasting versus post load plasma glucose concentration and the risk for future type 2 diabetes: results from the Botnia study. Diabetes Care. 2009;32:281\u20136.","journal-title":"Diabetes Care"},{"key":"412_CR28","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.2337\/dc08-0225","volume":"31","author":"MA Abdul-Ghani","year":"2008","unstructured":"Abdul-Ghani MA, Abdul-Ghani TA, Ali N, DeFronzo RA. One hour plasma glucose concentration and the metabolic syndrome identify subjects at high risk for future type 2 diabetes. Diabetes Care. 2008;31:1650\u20135.","journal-title":"Diabetes Care"}],"container-title":["BMC Endocrine Disorders"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-019-0412-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12902-019-0412-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-019-0412-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,20]],"date-time":"2020-08-20T23:15:28Z","timestamp":1597965328000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcendocrdisord.biomedcentral.com\/articles\/10.1186\/s12902-019-0412-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,22]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["412"],"URL":"https:\/\/doi.org\/10.1186\/s12902-019-0412-1","relation":{},"ISSN":["1472-6823"],"issn-type":[{"value":"1472-6823","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,22]]},"assertion":[{"value":"8 August 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 July 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 August 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study protocol was approved by the Board of the Ethical Committee of Hamad Medical Corporation (HMC ethical committee) and informed written consent was obtained from participants prior to enrollment.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"87"}}